Clinical syndromic diagnoses were established prior to genetic testing for 5/70 (7.1%) individuals in the non-SCN1A cohort: two individuals with Angelman syndrome, and one individual each with Lennox–Gastaut syndrome, Landau–Kleffner syndrome and Jeavons syndrome. The gene discussed is SCN1A; the disease is epilepsy with eyelid myoclonia.